
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
Raveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 2433-2445
Open Access | Times Cited: 192
Raveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 2433-2445
Open Access | Times Cited: 192
Showing 1-25 of 192 citing articles:
Animal models for COVID-19
César Muñoz‐Fontela, William E. Dowling, Simon G. P. Funnell, et al.
Nature (2020) Vol. 586, Iss. 7830, pp. 509-515
Open Access | Times Cited: 800
César Muñoz‐Fontela, William E. Dowling, Simon G. P. Funnell, et al.
Nature (2020) Vol. 586, Iss. 7830, pp. 509-515
Open Access | Times Cited: 800
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Ahmed O. Hassan, Natasha M. Kafai, Igor P. Dmitriev, et al.
Cell (2020) Vol. 183, Iss. 1, pp. 169-184.e13
Open Access | Times Cited: 529
Ahmed O. Hassan, Natasha M. Kafai, Igor P. Dmitriev, et al.
Cell (2020) Vol. 183, Iss. 1, pp. 169-184.e13
Open Access | Times Cited: 529
The origins of SARS-CoV-2: A critical review
Edward C. Holmes, Stephen A. Goldstein, Angela L. Rasmussen, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4848-4856
Open Access | Times Cited: 447
Edward C. Holmes, Stephen A. Goldstein, Angela L. Rasmussen, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4848-4856
Open Access | Times Cited: 447
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
Fatai S. Oladunni, Jun‐Gyu Park, Paula A. Pino, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 368
Fatai S. Oladunni, Jun‐Gyu Park, Paula A. Pino, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 368
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Kris M. White, Romel Rosales, Soner Yildiz, et al.
Science (2021) Vol. 371, Iss. 6532, pp. 926-931
Open Access | Times Cited: 313
Kris M. White, Romel Rosales, Soner Yildiz, et al.
Science (2021) Vol. 371, Iss. 6532, pp. 926-931
Open Access | Times Cited: 313
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
Kelvin Kai‐Wang To, Siddharth Sridhar, Kelvin Hei‐Yeung Chiu, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 507-535
Open Access | Times Cited: 297
Kelvin Kai‐Wang To, Siddharth Sridhar, Kelvin Hei‐Yeung Chiu, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 507-535
Open Access | Times Cited: 297
Virus-induced senescence is a driver and therapeutic target in COVID-19
Soyoung Lee, Yong Yu, Jakob Trimpert, et al.
Nature (2021) Vol. 599, Iss. 7884, pp. 283-289
Open Access | Times Cited: 268
Soyoung Lee, Yong Yu, Jakob Trimpert, et al.
Nature (2021) Vol. 599, Iss. 7884, pp. 283-289
Open Access | Times Cited: 268
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras, Rhys Jones, Brandon J. Anson, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 261
Britton Boras, Rhys Jones, Brandon J. Anson, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 261
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
Tia A. Tummino, Veronica V. Rezelj, Benoit Fischer, et al.
Science (2021) Vol. 373, Iss. 6554, pp. 541-547
Open Access | Times Cited: 185
Tia A. Tummino, Veronica V. Rezelj, Benoit Fischer, et al.
Science (2021) Vol. 373, Iss. 6554, pp. 541-547
Open Access | Times Cited: 185
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
Tirosh Shapira, I. Abrrey Monreal, Sébastien P. Dion, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 340-348
Open Access | Times Cited: 171
Tirosh Shapira, I. Abrrey Monreal, Sébastien P. Dion, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 340-348
Open Access | Times Cited: 171
Immune responses during COVID-19 infection
Cléa Melenotte, Aymeric Silvin, Anne-Gaëlle Goubet, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 146
Cléa Melenotte, Aymeric Silvin, Anne-Gaëlle Goubet, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 146
IL-13 is a driver of COVID-19 severity
Alexandra N. Donlan, Tara E. Sutherland, Chelsea Marie, et al.
JCI Insight (2021)
Open Access | Times Cited: 137
Alexandra N. Donlan, Tara E. Sutherland, Chelsea Marie, et al.
JCI Insight (2021)
Open Access | Times Cited: 137
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
Raveen Rathnasinghe, Sonia Jangra, Anastasija Čupić, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 132
Raveen Rathnasinghe, Sonia Jangra, Anastasija Čupić, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 132
The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models
Rafał Butowt, Nicolas Meunier, Bertrand Bryche, et al.
Acta Neuropathologica (2021) Vol. 141, Iss. 6, pp. 809-822
Open Access | Times Cited: 117
Rafał Butowt, Nicolas Meunier, Bertrand Bryche, et al.
Acta Neuropathologica (2021) Vol. 141, Iss. 6, pp. 809-822
Open Access | Times Cited: 117
Neurological complications and infection mechanism of SARS-CoV-2
Dandan Wan, Tingfu Du, Weiqi Hong, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 111
Dandan Wan, Tingfu Du, Weiqi Hong, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 111
Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates
Shuyu Shou, Menghui Liu, Yang Yang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 108
Shuyu Shou, Menghui Liu, Yang Yang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 108
Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication
Junjun Chu, Changsheng Xing, Yang Du, et al.
Nature Metabolism (2021) Vol. 3, Iss. 11, pp. 1466-1475
Open Access | Times Cited: 103
Junjun Chu, Changsheng Xing, Yang Du, et al.
Nature Metabolism (2021) Vol. 3, Iss. 11, pp. 1466-1475
Open Access | Times Cited: 103
Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
Mariano Carossino, Devin Kenney, Aoife K. O’Connell, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 535-535
Open Access | Times Cited: 69
Mariano Carossino, Devin Kenney, Aoife K. O’Connell, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 535-535
Open Access | Times Cited: 69
Endothelial cell infection and dysfunction, immune activation in severe COVID-19
Zhongnan Qin, Fengming Liu, Robert V. Blair, et al.
Theranostics (2021) Vol. 11, Iss. 16, pp. 8076-8091
Open Access | Times Cited: 98
Zhongnan Qin, Fengming Liu, Robert V. Blair, et al.
Theranostics (2021) Vol. 11, Iss. 16, pp. 8076-8091
Open Access | Times Cited: 98
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals
David A. Meekins, Natasha N. Gaudreault, Jüergen A. Richt
Viruses (2021) Vol. 13, Iss. 10, pp. 1993-1993
Open Access | Times Cited: 93
David A. Meekins, Natasha N. Gaudreault, Jüergen A. Richt
Viruses (2021) Vol. 13, Iss. 10, pp. 1993-1993
Open Access | Times Cited: 93
Replication, pathogenicity, and transmission of SARS-CoV-2 in minks
Lei Shuai, Gongxun Zhong, Quan Yuan, et al.
National Science Review (2020) Vol. 8, Iss. 3
Open Access | Times Cited: 85
Lei Shuai, Gongxun Zhong, Quan Yuan, et al.
National Science Review (2020) Vol. 8, Iss. 3
Open Access | Times Cited: 85
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
Weina Sun, Yonghong Liu, Fatima Amanat, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 84
Weina Sun, Yonghong Liu, Fatima Amanat, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 84
Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
Fatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, et al.
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 79
Fatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, et al.
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 79
Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS‐CoV‐2 infection
Jia‐Mei Liu, Bai‐Hong Tan, Shuang Wu, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 3, pp. 1304-1313
Open Access | Times Cited: 78
Jia‐Mei Liu, Bai‐Hong Tan, Shuang Wu, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 3, pp. 1304-1313
Open Access | Times Cited: 78
Animal models for SARS‐CoV‐2 research: A comprehensive literature review
Kabita Pandey, Arpan Acharya, Mahesh Mohan, et al.
Transboundary and Emerging Diseases (2020) Vol. 68, Iss. 4, pp. 1868-1885
Open Access | Times Cited: 73
Kabita Pandey, Arpan Acharya, Mahesh Mohan, et al.
Transboundary and Emerging Diseases (2020) Vol. 68, Iss. 4, pp. 1868-1885
Open Access | Times Cited: 73